Ticker
BIOACompany Name
BIOAGE LABS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 220.33M | $ 8.75M | $ -56.35M | $ 155.23M |
3/31/2025 | $ 257.49M | $ 10.31M | $ -105.57M | $ 141.61M |
12/31/2024 | $ 354.35M | $ 8.7M | $ -188.62M | $ 157.02M |
9/30/2024 | $ 334.47M | $ 10.21M | $ 414.94M | $ 739.2M |
6/30/2024 | $ 159.09M | $ 11.71M | $ 0 | $ 0 |
12/31/2023 | $ 24.96M | $ 53.25M | $ 0 | $ 0 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap + Debt - CashnEq
(=) EV
EV for BIOAGE LABS INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 53.25M ] - CashnEq [ $ 24.96M ]
(=) EV [ $ 0 ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 3.32K |
---|---|
min | $ -1.69B |
max | $ 6.83B |
average | $ 1.25B |
median | $ 439.42M |
std | $ 1.67B |